2020年三季度生信类文章见刊趋势分析

2020年三季度生信类文章见刊趋势分析

2020年已过大半,在第三季度期间国自然科学基金第二批(医学部)评审结果已经公布,2020年诺贝尔奖所有奖项也已尘埃落定,就连我们翘首以盼大半年的国庆假期也已经结束了!!!接下来就要盼过年了,你的SCI论文发表进展如何了呢?!

之前猫哥发布2020生信分析SCI见刊趋势分析【2020生信分析SCI见刊趋势分析(独家)】,给大家分析了生信SCI见刊趋势并推荐了生信友好期刊。那在第三季度的几个月里生信SCI发表情况有变动吗?生信SCI见刊趋势还乐观吗?生信友好期刊还依然友好吗?我们再来一探究竟~~~

2020年三季度生信类文章见刊趋势分析

小编在Pubmed中,检索了2020年“GEO”“TCGA”等相关关键词,发现2020年第三季度7月-9月有1379篇SCI,可见生信SCI见刊趋势有增无减!那这些文章都是在哪些期刊发表的?我们来仔细扒一扒!

2020年三季度发表的生信SCI,按照期刊接收的文章数量排序,TOP10的期刊是:OncolLett(2.31分)、FrontOncol(4.85分)、BiomedRes Int(2.28分)、CancerCell Int(4.18分)、Aging (Albany NY)(4.83分)、Cancers (6.126分)、Int J Immunopharmacol(3.94分)、Front Genet(3.26 分)、J CELL MOL MED(4.49分)、OncoTargets Ther(3.34分)。(小编惊喜的发现这个排名与2020年上半年生信SCI友好期刊排名竟大同小异,果然称得上生信友好期刊!)

2020生信友好期刊

接收量

最新IF

OncolLett

49

2.311

FrontOncol

48

4.848

BiomedRes Int

40

2.276

CancerCell Int

35

4.175

Aging (Albany NY)

34

4.83

Cancers

32

6.126

Int J Immunopharmacol

31

3.943

Front Genet

27

3.258

J CELL MOL MED

26

4.486

OncoTargets Ther

26

3.337

Biosci Rep

23

2.942

Cancer Med

23

3.491

Medicine

23

1.552

Sci Rep

23

3.998

J Cancer

22

3.565

BMC cancer

19

3.150

Mol Med Rep

17

2.100

Am J Transl Res

15

3.375

Cancer Manag Res

15

2.886

DNA Cell Biol

15

3.191

Med Sci Monitor

15

1.92

Genomics

14

6.205

Theranostics

14

8.579

Gene

13

2.984

J Transl Med

13

4.124

Oncol Rep

13

3.417

Exp Ther Med

12

1.785

Pathol Res Pract

12

2.06

PeerJ

12

2.379

PloS one

11

2.740

Cancer Immunol Immun

10

5.44

Front Cell Dev Biol

10

5.201

J Cancer Res Clin Oncol

10

3.656

J Cell Physiol

10

5.546

J Comput Biol

10

1.05

BMC Med Genomics

9

2.570

Com Chem High T Sci

9

1.195

Clin Cancer Res

8

10.11

Eur Rev Med Pharmaco

8

3.024

Front Pharmacol

8

4.225

Int J Cancer

8

5.145

Int J Mol Sci

8

4.556

J Exp  Clin Cancer Res

8

7.07

Bioinformatics

7

5.62

Int J Med Sci

7

2.523

Life Sci

7

3.647

Brief Bioinform

6

8.990

Cell Death & Dis

6

6.304

J Cell Biochem

6

4.237

J Thorac Oncol

6

2.206

J Int Med Res

6

1.29

生信SCI友好期刊影响因子排序:

2020生信友好期刊

2020-IF因子

接收量

Clin Cancer Res

10.107

8.00

Brief Bioinform

8.990

6.00

Theranostics

8.579

14.00

J Exp  Clin Cancer Res

7.068

8.00

Cell Death & Dis

6.304

6.00

Genomics

6.205

14.00

Cancers

6.126

32.00

Bioinformatics

5.615

7.00

J Cell Physiol

5.546

10.00

Cancer Immunol Immun

5.442

10.00

Front Cell Dev Biol

5.201

10.00

Int J Cancer

5.145

8.00

FrontOncol

4.848

48.00

Aging (Albany NY)

4.831

34.00

Int J Mol Sci

4.556

8.00

J CELL MOL MED

4.486

26.00

J Cell Biochem

4.237

6.00

Front Pharmacol

4.225

8.00

CancerCell Int

4.175

35.00

J Transl Med

4.124

13.00

Sci Rep

3.998

23.00

Int J Immunopharmacol

3.943

31.00

J Cancer Res Clin Oncol

3.656

10.00

Life Sci

3.647

7.00

J Cancer

3.565

22.00

Cancer Med

3.491

23.00

Oncol Rep

3.417

13.00

Am J Transl Res

3.375

15.00

OncoTargets Ther

3.337

26.00

Front Genet

3.258

27.00

DNA Cell Biol

3.191

15.00

BMC cancer

3.150

19.00

Eur Rev Med Pharmaco

3.024

8.00

Gene

2.984

13.00

Biosci Rep

2.942

23.00

Cancer Manag Res

2.886

15.00

PloS one

2.740

11.00

BMC Med Genomics

2.570

9.00

Int J Med Sci

2.523

7.00

PeerJ

2.379

12.00

OncolLett

2.311

49.00

BiomedRes Int

2.276

40.00

J Thorac Oncol

2.206

6.00

Mol Med Rep

2.100

17.00

Pathol Res Pract

2.059

12.00

Med Sci Monitor

1.918

15.00

Exp Ther Med

1.785

12.00

Medicine

1.552

23.00

J Int Med Res

1.287

6.00

Com Chem High T Sci

1.195

9.00

J Comput Biol

1.054

10.00

2020年三季度生信类文章见刊趋势分析

想知道高分文章idea?哈哈,多看文章多总结!下面我们列举出了最新的高分文章,影响因子均在10分以上。

文章标题(IF>10)

MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.

Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning

ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate

FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer

A user guide for the online exploration and visualization of PCAWG data.

Sex differences in oncogenic mutational processes.

Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples

TIMER2.0 for analysis of tumor-infiltrating immune cells.

CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts

Weakly Supervised Deep Learning for Whole Slide Lung Cancer Image Analysis.

Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz

Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

TET1 promotes malignant progression of cholangiocarcinoma with IDH1 wild-type.

Whole Exome Profiling of NSCLC Among African Americans.

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.

TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations

Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8 + T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma

TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial

A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma

Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

2020年三季度生信类文章见刊趋势分析

什么?10+文章太难搞!那我们再来看看5-10分都有哪些文章

影响因子在5-10分的杂志里Cancers 发布的纯生信文章最多,但是竟还是几乎没有中国单位发表的。。。好吧,下面我们只列举既对生信文章友好,又对中国单位友好的期刊Genomics、J Cell Physiol、Cancer Immunol Immunother的生信文章列表。(想投5-10分的纯生信文章,这三个期刊是首选哦!)

文章标题(10>IF>5)

Prognostic significance of ARL9 and its methylation in low-grade glioma.

Estimating gene expression from DNA methylation and copy number variation: A deep

Minimum error calibration and normalization for genomic copy number analysis.

Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer

Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma

Identification and validation of a six-lncRNA prognostic signature with its ceRNA networks and candidate drugs in lower-grade gliomas

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment

Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer

Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis

Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma

CancerEnD: A database of cancer associated enhancers.

Construction and validation of a TP53-associated immune prognostic model for gastric cancer

A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors

Identifying potential DNA methylation markers in early-stage colorectal Cancer.

A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis

The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma

DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies

A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer

The prognostic value and potential subtypes of immune activity scores in three major urological cancers

Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores

Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma

Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma

PSMC6 promotes osteoblast apoptosis through inhibiting PI3K/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model

Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC

Tumor immune microenvironment in cancer patients with leukocytosis.

Tumor-infiltrating CD39 + CD8 + T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients

Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)

ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

Immune checkpoint-related serum proteins and genetic variants predict outcomes of localized prostate cancer, a cohort study

Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models

Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8 + T cells in gastric cancer

Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets

Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis

看到这里是不是有些小心动,也想来一篇了呢?发文要趁早,年底冲刺,Fighting!!!

 

 

注:此推文未经许可禁止转载!
阅读推荐:
  • 绘图技能|用AI快速绘制一个丙肝病毒

  • 生信技能|如何花5分钟给你的Paper加几张Figure?

  • 文献详解|如何利用多个数据库进行生信挖掘发表8+分SCI文章

  • 技术传递|你想要了解的表观遗传学知识都在这里,你确定不看下吗(ATAC-seq)?

  • 看图说话|GSEA分析--教你解锁高级的富集分析

如果您或者科室有科研上的困扰
扫码备注:科研思路探讨

2020年三季度生信类文章见刊趋势分析

2020年三季度生信类文章见刊趋势分析

生物医学科研方法

OA还没有版面费的4分优质期刊,不容错过

2020-11-19 6:06:08

生物医学科研方法

Nature子刊:晴天霹雳!十年监测发现,最安全基因治疗载体AAV,竟有潜在致癌性

2020-11-19 6:15:11